What fills me with confidence is that Dr Sud was working on a treatment for SAARDS a few years prior too the pandemic.Its not like he's jumped on the let's get a medication/treatment for Covid 19 bandwagon.He has instead put this trial at the forefront of the company with the years of research he's been gathering as it could help save lives,if this is successful the company will be very highly regarded moving into OSA and TBI trails.
IHL Price at posting:
7.0¢ Sentiment: Hold Disclosure: Held